Your Cart

Imagion Biosystems March 2021 Investor Newsletter

Imagion Biosystems March 2021 Investor Newsletter

Imagion Biosystems is pleased to provide its investors with its March 2021 Investor Newsletter. The newsletter details recent new company developments and activities, including:

  • Message from the CEO, Mr Robert Proulx
  • Study design at a glance – MagSense® HER2 breast cancer Phase 1 study
  • CSIRO funding received to jump start prostate cancer project
  • Prostate Cancer Q&A with Professor Lisa Horvarth, IBX Scientific Advisory Board and Professor Roger Daly, Monash University
  • Imagion Biosystems 2020 Annual Report
  • How to exercise your options

The investor newsletter can be viewed here. Imagion Biosystems normally distributes this update as an e-newsletter. Investors can sign up to receive email updates at this link:

Related Articles

1H2023 Half-Year Results

1H2023 Highlights: Achieved enrolment target for Phase I study of MagSense® HER2 breast cancer detection; imaging results corroborated by independent panel of radiologists Announced plan

Read More

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.